EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The GLP ‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap

Ramy Awadalla iD, Derek Davies iD

International Journal of Dermatology · 2026-07 · 65 (7) · 1361-1362

DOI: 10.1111/ijd.70348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 24.02.2026. Verfasst von Ramy Awadalla und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Rural Medicine, Charles Sturt University, Orange, New South Wales, Australia. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

drug eruptionsdrug‐related side effects and adverse reactionsglucagon‐like peptide‐1 receptorincretinspsoriasis

Autor:innen und Institutionen

  • School of Rural Medicine, Charles Sturt University, Orange, New South Wales, Australia.
  • Westderm Dermatology Clinics, Orange, New South Wales, Australia.

ORCID-Profile: Ramy Awadalla, Derek Davies

Zitieren

APA

Awadalla, R., & Davies, D. (2026). The GLP ‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap. International Journal of Dermatology, 65(7), 1361-1362. https://doi.org/10.1111/ijd.70348

Vancouver

Awadalla R, Davies D. The GLP ‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap. International Journal of Dermatology. 2026;65(7):1361-1362. doi:10.1111/ijd.70348

BibTeX
@article{Awadalla2026,
  author = {Awadalla, Ramy and Davies, Derek},
  title = {The GLP ‐1 Receptor Agonist Paradox in Dermatology: Why We Cannot Afford the Knowledge Gap},
  journal = {International Journal of Dermatology},
  year = {2026},
  volume = {65},
  number = {7},
  pages = {1361--1362},
  doi = {10.1111/ijd.70348}
}
Kostenlos starten →